FIG. 1.

Schematic diagram depicting the concept of targeted radionuclide therapy employing either alpha (α) or beta (β⁻) particles in a tumor-targeting construct. The high LET and short range of α particles make them highly desirable for use in cancer therapy. LET, linear energy transfer.